Innovative Approaches to Head and Neck Cancer Diagnosis
- PMID: 41062406
- DOI: 10.1016/j.otc.2025.08.017
Innovative Approaches to Head and Neck Cancer Diagnosis
Abstract
Diagnosis, positioned between disease prevention and treatment, is essential for head and neck cancer management. Delays in diagnosis contribute to disease upstaging, leading to more complex treatment with poorer survival and functional outcomes. This article focuses on current and future innovative diagnostic approaches, which vary in maturity and implementation, to promote early diagnosis. These include symptom-based triaging, telemedicine, diagnostic hubs, machine learning, and circulating tumor markers. COVID-19 brought about new diagnostic pathways, many of which remained in place, generating encouraging evidence of pathway efficiency. However, nuanced diagnostic tools for early cancer detection remain far from implementation in a real-world setting.
Keywords: Biomarkers; Diagnostic pathways; Machine learning; Radiomics; Telemedicine; Triage.
Crown Copyright © 2025. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosures A. George is the medical Director for endoscope-i Ltd who contract with the National Health Service for Telemedicine Head and Neck Cancer pathways. T. Tikka has developed the HaNC-RC v.2. D. Conway is a member of the Head and Neck Cancer in South America and Europe Consortium funded by European Union's (HEADSpAcE) Consortium Horizon 2020 research and innovation program under Grant Agreement No. 825771.
Publication types
LinkOut - more resources
Full Text Sources